| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2172706 | Cytotherapy | 2006 | 12 Pages |
Abstract
The presence of aberrantly glycosylated MUC1 may influence Ag presentation of the tumor glycoforms of MUC1 to immune cells, affecting tumor cell killing. These findings could be highly relevant to developing strategies for cancer immunotherapy based on DC vaccines using MUC1 as tumor Ag.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
E.B.M. (Dr), S. Cloosen, B.L.M.G. Senden-Gijsbers, M. Agervig Tarp, U. Mandel, H. Clausen, M.J.E. Havenga, M.-T. Duffour, J.J. GarcÃa-Vallejo, W.T.V. Germeraad, G.M.J. Bos,